White House drops Heidi Overton pick for FDA chief

News

At the eleventh hour, the White House has rescinded its nomination of Heidi Overton – a staunch Trump ally – to be FDA Commissioner, extending the permanent leadership vacuum at the agency.

The decision – first reported by Axios and subsequently confirmed by a White House spokesperson – came on the eve of a meeting of the Senate Health, Education, Labor and Pensions (HELP) Committee, where a vote was scheduled to be taken on advancing her nomination for a full Senate confirmation hearing.

The FDA has been led on an acting basis by Kyle Diamantas since Marty Makary stepped down in May, after 13 months in the role.

Donald Trump nominated Overton – a White House aide, physician, and vocal opponent of abortion – in the summer. The following month, Overton faced a grilling at a Senate hearing, at which she was quizzed on a range of issues, including vaccines, the abortion pill, and FDA reforms.

What was remarkable at the hearing was Overton's apparent inability to acknowledge that Trump could be wrong on any issue, raising concerns that she would not stand up to the President if asked to do something illegal or contrary to good regulatory practice, which seems to have worried even Republican lawmakers.

HELP chair, Senator Bill Cassidy (R-La), is among those who have previously expressed doubts about her suitability for the role, particularly her support for a Kennedy-led plan to break up combination paediatric vaccines into separate shots, which he called unscientific.

He seems to have changed his tune, however, writing in a social media post that the White House had "abandoned a viable confirmation path" for Overton, adding: "My conversations with her convinced me she would follow the science and push back against decisions that put Americans' health at risk."

The sticking point, according to Cassidy, was assurances sought by anti-abortion Senators to which the White House was unable to commit.

Cassidy's change of position on Overton is something of a surprise, considering that he cast the deciding vote that allowed vaccine sceptic Robert F. Kennedy Jr to become HHS Secretary, and has since accused Kennedy of reneging on commitments he had given him in order to secure his support.

"Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats," he added. The Democrats' resounding win in the midterms means that the HELP committee will see dramatic personnel changes when victorious Senators assume their offices on 3rd January.

To advance to a full Senate vote, Overton would have needed 11 votes in the 21-member HELP committee, which meant she would have needed the support of all Republicans on the panel.

The withdrawal of Overton's nomination has been applauded by advocacy group Reproductive Freedom for All, claiming that Republicans had been "shamelessly trying to shoehorn her nomination through the final weeks of their majority to undermine the future of abortion medication."

That is a pressing topic at the moment, as the FDA is currently conducting a review of the abortion medication mifepristone, with a decision due next March, which the group has labelled politically motivated and a "sham."